Business · 04/12/2013
FDA Requests Nominations for Bulk Drug Substances for Outsourcing Facilities
The FDA is seeking nominations for bulk drug substances that can be used to compound drug products in accordance with the FD&C Act, with the goal of identifying suitable outsourcing facilities.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →